Surrozen, Inc. (SRZN)
NASDAQ: SRZN · Real-Time Price · USD
29.13
-0.19 (-0.65%)
At close: Oct 5, 2026, 4:00 PM EDT
29.05
-0.08 (-0.27%)
After-hours: Oct 5, 2026, 4:40 PM EDT
Surrozen Market Cap
Surrozen has a market cap or net worth of $342.38 million as of October 5, 2026. Its market cap has increased by 191.92% in one year.
Market Cap
342.38M
Enterprise Value
246.66M
1-Year Change
191.92%
Ranking
Category
Stock Price
$29.13
ChartMarket Cap Chart
Since January 11, 2021, Surrozen's market cap has increased from $120.65M to $342.38M, an increase of 183.77%. That is a compound annual growth rate of 19.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 342.38M | 62.50% |
| Dec 31, 2025 | 210.69M | 351.80% |
| Dec 31, 2024 | 46.63M | 143.39% |
| Dec 29, 2023 | 19.16M | 10.72% |
| Dec 30, 2022 | 17.31M | -92.33% |
| Dec 31, 2021 | 225.58M | 86.96% |
| Jan 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Agenus | 376.37M |
| Arcturus Therapeutics Holdings | 370.35M |
| Inhibikase Therapeutics | 364.15M |
| C4 Therapeutics | 362.92M |
| Fennec Pharmaceuticals | 357.69M |
| Orchestra BioMed Holdings | 357.63M |
| Ocugen | 345.89M |
| Cabaletta Bio | 339.09M |